The evolution of insulin therapy: innovations, challenges, and future prospects is reshaping diabetes management, offering improved formulations and delivery systems. Ultra-rapid and ultra-long-acting insulins provide greater flexibility, reducing the risk of hypoglycemia while optimizing glucose control. Smart insulin pens and continuous glucose monitoring integration enhance precision in dosing. However, challenges such as cost, adherence, and weight gain remain significant barriers to widespread adoption. Research is advancing toward glucose-responsive insulins and implantable delivery systems that mimic pancreatic function. As personalized medicine continues to drive innovation, novel insulin analogs and alternative routes of administration, including oral and inhaled formulations, hold promise for the future of diabetes treatment.
Submit your abstract Today
